Tuesday, March 17, 2026

Dollar-Won Exchange Rate Could Top 1,450 with Trump’s Tariffs Causing Market Jitters

Woori Bank predicts the dollar-won rate may exceed 1,450 won due to tariff pressures and market reactions to trade disputes.

North Korea’s Olympic Broadcast Secret: What They’re Hiding From the World

North Korea's state-run television has begun streaming its first Olympic TV broadcast nine days after the opening of the Paris Olympics.

Under the Radar: How North Korea Continues to Skirt International Sanctions

North Korea has once again been caught...

Tag: medication

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

New Diabetes Treatment: Chong Kun Dang’s Dubiempol Sustained Release Tablet Approved for Type 2 Diabetes in Korea

Chong Kun Dang's type 2 diabetes treatment, Dubiempol, gains approval, offering a new option for patients with uncontrolled blood sugar.

Discover the Breakthrough: Daewoong’s CleanCol Tablet Reduces Dosage for Effective Colon Cleansing

Daewoong Pharmaceutical's Cleancol Tab. shows effective bowel cleansing with fewer tablets, improving patient adherence during colonoscopy prep.

Brivaracetam vs. Levetiracetam: Which Epilepsy Drug Offers Better Safety and Efficacy?

Samjin Pharmaceutical launches Bricetam Tablets, improving epilepsy treatment with fewer side effects and better adherence for patients.

Unlocking Weight Loss: How Celltrion’s New CT-G32 and Oral Multi-Action Drug Will Change the Game

Celltrion aims to lead the obesity treatment market with innovative drugs, enhancing efficacy and patient convenience through dual approaches.

South Korean Biotech Seeks Breakthrough in $Trillion-Scale Alzheimer’s Market

AriBio's AR1001 is a promising oral Alzheimer's drug aiming for global blockbuster status by 2027, focusing on convenience and safety.

How SK Chemical’s Nose-R Soft Cap Stand Out in Allergy Treatment: A Deep Dive into the OTC Market

SK Chemicals partners with Kyung Nam Pharm to enhance Nose-R Soft Cap sales in pharmacies, boosting allergy treatment distribution.

Novo Nordisk’s Oral Wegovy Tops 3,000 Prescriptions in Its First Week—A Challenge to Injectable GLP-1s

Novo Nordisk's Wegovy oral treatment exceeds 3,000 prescriptions in its debut week, signaling a shift towards oral obesity medications.

Is RPG-102 the Future of Obesity Treatment? Discover the Breakthrough Oral Solution!

ProGen and Rani Therapeutics initiate a Phase 1 trial for RPG-102, an oral obesity treatment, aiming for effective weight loss with weekly dosing.

Novo Nordisk Pushes for First Oral Obesity Drug Approval

Novo Nordisk seeks FDA approval for oral Wegovy, potentially the first oral obesity treatment, amid competition with Eli Lilly.

Long-Acting HIV Treatment Vocabria + Rekambys Offers New Hope with Just Six Injections a Year

Long-acting HIV treatment Vocabria + Rekambys improves adherence and quality of life, reducing daily pill burden to six injections yearly.

Safe Medication Use During Pregnancy: What You Need to Know

Expectant mothers should consult healthcare providers about medication use during pregnancy to ensure safety for both mother and baby.

New Hope for Alcohol-Related Liver Disease: GLP-1 Drugs Show Promise

Research shows that GLP-1 receptor agonists, like Wegovy, may help combat alcohol-related liver disease, reducing liver cancer risk.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.